Study programme 2021-2022 | Français | ||
Drugs & Strategies for Cancer Treatment | |||
Programme component of Master's in Biomedical Sciences à la Faculty of Medicine and Pharmacy |
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-M2-BIOMED-031-M | Optional UE | JOURNE Fabrice | M112 - Anatomie humaine et Oncologie expérimentale |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Anglais | 15 | 0 | 0 | 0 | 0 | 2 | 2.00 | 1st term |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-ANBC-300 | Drugs & Strategies for Cancer Treatment - Part 1 | 10 | 0 | 0 | 0 | 0 | Q1 | |
M-ANBC-303 | Drugs & Strategies for Cancer Treatment - Part 2 | 5 | 0 | 0 | 0 | 0 | Q1 |
Programme component |
---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
First-line cancer treatment. The course will be teached in english.
Content of UE
This course will develop the systemic treatment of cancer including chemotherapy, hormone therapy, targeted therapies (against signaling pathways and mutations), and immunotherapy. Cancer chemotherapy uses drugs that interfere with cell growth leading to cell death (cytotoxic drugs) or stopping cell proliferation (cytostatic drugs). This course will also discuss the importance of multidrug therapy. In the context of integrative oncology, the coordination of care between the pharmacist, the doctor and the hospital is important. The efficacy of anticancer treatments and the associated adverse effects will be discussed, in particular concerning the dermatological toxicity of oncological treatments. Finally, the role of pharmacists in supportive care will be presented.
Prior Experience
Not applicable
Type of Assessment for UE in Q1
Method of calculating the overall mark for the Q1 UE assessment
/
Q1 UE Assessment Comments
None
Type of Assessment for UE in Q3
Method of calculating the overall mark for the Q3 UE assessment
/
Q3 UE Assessment Comments
None
Method of calculating the overall mark for the Q1 UE resit assessment
/
Type of Resit Assessment for UE in Q1 (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
None
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-ANBC-300 |
|
M-ANBC-303 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-ANBC-300 |
|
M-ANBC-303 |
|
Required Reading
AA | |
---|---|
M-ANBC-300 | |
M-ANBC-303 |
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-ANBC-300 | Not applicable |
M-ANBC-303 | Not applicable |
Recommended Reading
AA | |
---|---|
M-ANBC-300 | |
M-ANBC-303 |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-ANBC-300 | Not applicable |
M-ANBC-303 | Not applicable |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-ANBC-300 | Not applicable |
M-ANBC-303 | Not applicable |